United States · FDA National Drug Code directory
Azithromycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-2026_51fdb1a5-1cac-49eb-a6bd-20776c9aa03b
- Product NDC
- 0093-2026
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Azithromycin
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101217
- Source listing expiry
- 20271231
Source-listed ingredients
- AZITHROMYCIN MONOHYDRATE — 200 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 15 mL in 1 BOTTLE (0093-2026-23) · 0093-2026-23
- 30 mL in 1 BOTTLE (0093-2026-31) · 0093-2026-31
- 22.5 mL in 1 BOTTLE (0093-2026-94) · 0093-2026-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →